Diclofensine
ro8-4650
Stimulant, Research-chemical, Tentative, Habit-forming
A triple monoamine reuptake inhibitor developed by Hoffman-LaRoche in the 1970s as an antidepressant but discontinued. It is suspected that it was discontinued due to high abuse potential. Acts as an SNDRI, the drug mainly inhibits dopamine and noradrenaline.
NOTE: These doses are tentative and it is recommended to do further research.
Chart shows bounded mass ranges in mg. See the table for all doses.
Threshold
Light
Common
Heavy
Oral
12-15mg
30-40mg
40-60mg
60-80mg
Duration
Oral
4 to 6